Free Trial

GRAIL (GRAL) Competitors

GRAIL logo
$40.29 +0.57 (+1.44%)
Closing price 04:00 PM Eastern
Extended Trading
$40.17 -0.12 (-0.29%)
As of 05:42 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

GRAL vs. OPCH, RDNT, BTSG, SHC, SGRY, CON, PRVA, WGS, VCYT, and ARDT

Should you be buying GRAIL stock or one of its competitors? The main competitors of GRAIL include Option Care Health (OPCH), RadNet (RDNT), BrightSpring Health Services (BTSG), Sotera Health (SHC), Surgery Partners (SGRY), Concentra Group Holdings Parent (CON), Privia Health Group (PRVA), GeneDx (WGS), Veracyte (VCYT), and Ardent Health (ARDT). These companies are all part of the "healthcare" industry.

GRAIL vs. Its Competitors

Option Care Health (NASDAQ:OPCH) and GRAIL (NASDAQ:GRAL) are both medical companies, but which is the better stock? We will compare the two companies based on the strength of their risk, profitability, earnings, institutional ownership, analyst recommendations, valuation, dividends and media sentiment.

Option Care Health has a net margin of 4.12% compared to GRAIL's net margin of -1,464.53%. Option Care Health's return on equity of 16.90% beat GRAIL's return on equity.

Company Net Margins Return on Equity Return on Assets
Option Care Health4.12% 16.90% 7.00%
GRAIL -1,464.53%-17.99%-15.02%

Option Care Health presently has a consensus price target of $35.50, indicating a potential upside of 19.57%. GRAIL has a consensus price target of $31.50, indicating a potential downside of 21.82%. Given Option Care Health's stronger consensus rating and higher probable upside, analysts plainly believe Option Care Health is more favorable than GRAIL.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Option Care Health
0 Sell rating(s)
1 Hold rating(s)
7 Buy rating(s)
0 Strong Buy rating(s)
2.88
GRAIL
0 Sell rating(s)
3 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.25

Option Care Health has higher revenue and earnings than GRAIL. GRAIL is trading at a lower price-to-earnings ratio than Option Care Health, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Option Care Health$5.00B0.97$211.82M$1.2423.94
GRAIL$125.60M11.54-$2.03B-$60.99-0.66

In the previous week, GRAIL had 1 more articles in the media than Option Care Health. MarketBeat recorded 7 mentions for GRAIL and 6 mentions for Option Care Health. Option Care Health's average media sentiment score of 1.85 beat GRAIL's score of 1.48 indicating that Option Care Health is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Option Care Health
5 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive
GRAIL
5 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

98.1% of Option Care Health shares are owned by institutional investors. 0.6% of Option Care Health shares are owned by company insiders. Comparatively, 1.9% of GRAIL shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Summary

Option Care Health beats GRAIL on 12 of the 15 factors compared between the two stocks.

Get GRAIL News Delivered to You Automatically

Sign up to receive the latest news and ratings for GRAL and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding GRAL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

GRAL vs. The Competition

MetricGRAILMED IndustryMedical SectorNASDAQ Exchange
Market Cap$1.45B$3.04B$5.74B$9.51B
Dividend YieldN/A2.40%4.60%3.99%
P/E Ratio-0.6621.1828.1120.03
Price / Sales11.54337.65460.63103.88
Price / Cash1.4243.2336.5559.01
Price / Book0.548.368.655.90
Net Income-$2.03B-$55.19M$3.25B$258.66M
7 Day Performance14.49%5.89%4.20%2.23%
1 Month Performance-12.74%17.63%10.83%12.77%
1 Year Performance154.20%5.10%34.67%19.36%

GRAIL Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
GRAL
GRAIL
0.668 of 5 stars
$40.29
+1.4%
$31.50
-21.8%
+166.0%$1.45B$125.60M-0.661,360Positive News
OPCH
Option Care Health
4.5294 of 5 stars
$30.68
+2.7%
$35.50
+15.7%
-4.9%$5.02B$5.00B24.748,088Positive News
Upcoming Earnings
RDNT
RadNet
3.7619 of 5 stars
$56.59
+2.0%
$69.60
+23.0%
-12.0%$4.25B$1.87B-131.6011,021News Coverage
Positive News
BTSG
BrightSpring Health Services
1.7016 of 5 stars
$20.31
flat
$24.90
+22.6%
+71.6%$3.57B$11.86B72.5435,000News Coverage
Upcoming Earnings
SHC
Sotera Health
3.0908 of 5 stars
$11.61
-1.6%
$16.00
+37.8%
-9.5%$3.30B$1.10B145.143,000News Coverage
Positive News
SGRY
Surgery Partners
2.6789 of 5 stars
$22.47
+2.0%
$33.56
+49.3%
-29.2%$2.88B$3.11B-14.6915,000
CON
Concentra Group Holdings Parent
3.2264 of 5 stars
$20.23
+1.6%
$28.50
+40.9%
N/A$2.59B$1.90B15.0911,250News Coverage
PRVA
Privia Health Group
4.0861 of 5 stars
$20.89
+2.1%
$28.38
+35.9%
+0.3%$2.55B$1.80B174.101,140Positive News
WGS
GeneDx
3.9458 of 5 stars
$82.39
-0.2%
$92.33
+12.1%
+140.7%$2.35B$330.14M-58.431,200Upcoming Earnings
VCYT
Veracyte
3.6646 of 5 stars
$26.65
-1.6%
$40.90
+53.5%
+0.7%$2.09B$445.76M65.00790Positive News
Gap Up
ARDT
Ardent Health
3.548 of 5 stars
$14.51
+2.4%
$20.67
+42.4%
-35.5%$2.08B$5.97B8.9024,900

Related Companies and Tools


This page (NASDAQ:GRAL) was last updated on 7/25/2025 by MarketBeat.com Staff
From Our Partners